BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1612 related articles for article (PubMed ID: 20129363)

  • 1. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
    Lin CH; Balzer DT; Lasala JM
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):102-7. PubMed ID: 21416575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The Toronto Experience.
    Shah AH; Osten M; Leventhal A; Bach Y; Yoo D; Mansour D; Benson L; Wilson WM; Horlick E
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1928-38. PubMed ID: 27659570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience using the new GORE Septal Occluder at the margins.
    Lockhart CJ; Johnston NG; Spence MS
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1244-8. PubMed ID: 23418128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
    Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
    Becker M; Frings D; Schröder J; Ocklenburg C; Mühler E; Hoffmann R; Franke A; Lepper W
    J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.
    Fernando RR; Koranne KP; Barker CM
    Tex Heart Inst J; 2012; 39(5):647-52. PubMed ID: 23109759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
    Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
    Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of adult patients with atrial septal defects presenting with paradoxical embolism.
    Bannan A; Shen R; Silvestry FE; Herrmann HC
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1066-9. PubMed ID: 19670302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
    Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
    Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
    Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke due to late device thrombosis following successful percutaneous patent foramen ovale closure.
    Korabathina R; Thaler DE; Kimmelstiel C
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):498-502. PubMed ID: 21953702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.